- Home
- NDLS vs DXR Comparison
NDLS vs DXR Comparison
Compare NDLS & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NDLS
- DXR
- Stock Information
- Founded
- NDLS 1995
- DXR 1970
- Country
- NDLS United States
- DXR United States
- Employees
- NDLS N/A
- DXR N/A
- Industry
- NDLS Restaurants
- DXR Medical/Dental Instruments
- Sector
- NDLS Consumer Discretionary
- DXR Health Care
- Exchange
- NDLS Nasdaq
- DXR Nasdaq
- Market Cap
- NDLS 40.3M
- DXR 40.3M
- IPO Year
- NDLS 2013
- DXR N/A
- Fundamental
- Price
- NDLS $0.98
- DXR $7.83
- Analyst Decision
- NDLS Strong Buy
- DXR Strong Buy
- Analyst Count
- NDLS 2
- DXR 1
- Target Price
- NDLS $3.00
- DXR $25.00
- AVG Volume (30 Days)
- NDLS 84.8K
- DXR 4.7K
- Earning Date
- NDLS 05-07-2025
- DXR 01-01-0001
- Dividend Yield
- NDLS N/A
- DXR N/A
- EPS Growth
- NDLS N/A
- DXR 86.16
- EPS
- NDLS N/A
- DXR 0.11
- Revenue
- NDLS $493,271,000.00
- DXR $119,714.00
- Revenue This Year
- NDLS $4.57
- DXR N/A
- Revenue Next Year
- NDLS $1.29
- DXR N/A
- P/E Ratio
- NDLS N/A
- DXR $71.48
- Revenue Growth
- NDLS N/A
- DXR N/A
- 52 Week Low
- NDLS $0.55
- DXR $6.55
- 52 Week High
- NDLS $2.36
- DXR $10.00
- Technical
- Relative Strength Index (RSI)
- NDLS 46.30
- DXR 50.76
- Support Level
- NDLS $0.87
- DXR $7.35
- Resistance Level
- NDLS $0.96
- DXR $7.98
- Average True Range (ATR)
- NDLS 0.09
- DXR 0.36
- MACD
- NDLS 0.01
- DXR 0.01
- Stochastic Oscillator
- NDLS 59.78
- DXR 58.82
About NDLS Noodles & Company
Noodles & Co is a restaurant concept offering lunch and dinner within the fast-casual segment of the restaurant industry. The company's menu includes a variety of cooked-to-order dishes, including noodles and pasta, soups, salads and appetizers. The company also provides dining, pick-up and delivery services.
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.